Raising the Bar on Governance
Our goal is to provide our patients with the best in healthcare, be it innovative drugs, latest devices, new-age therapies or
novel initiatives. To meet our goals, we strive for excellence by going beyond compliance and setting new benchmarks in
accountability, transparency, and ethical behaviour.
Our Approach
Good corporate governance lays the foundation that helps us realise our vision of providing access to high-quality life-saving drugs. Guided by our values, our corporate governance philosophy aims to embed a culture of transparency, accountability and ethical behaviour across all levels of the organisation. A highly experienced and diverse Board at the top governs our activities while a strong risk management framework helps us identify risks and safeguard the interests of our investors, employees and customers. We are committed to strictly adhering to the highest standards of good governance and have a policy of zero tolerance towards any deviation.
FOCUS AREAS
The pillars of our corporate governance framework act as our focus areas and help us build trust, sharpen our decision-making process, promote ethical conduct and create long-term value.
Our Governance Structure
In addition to capability, it takes perseverance and action to achieve a purpose. A robust execution structure steers us in the right direction. Cipla’s multi-tiered governance structure has clearly defined roles and responsibilities for every member or position of the governance system to ensure accountability for every action. To effectively discharge the obligations and to comply with the statutory requirements, the Board has constituted six board committees.
Sustainability Governance Framework
We believe long-term economic growth can only be ensured with a positive ecological footprint and social impact. We have a well-thought-out sustainability governance framework to effectively manage the triple bottom line.
Responsibility for sustainability performance within Cipla is delegated to the Sustainability Council, who meet quarterly and is chaired by the Global Chief Manufacturing Officer.
Investment and Risk Management Committee of the Board has been designated with the responsibility of governance and execution of our Environment, Social and Governance (ESG) initiatives, as well as identification of critical risks and devising mitigation plans for the same.
Enterprise Risk Management
As a global pharmaceutical company, our operations are exposed to a variety of risks every day. A robust Enterprise Risk Management (ERM) framework enables us to manage our risks better and recognise new threats and their potential impact.
Our UN SDGs
